Filter posts

We Are the Worldview

Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective will have …

Integrate and Collaborate to Drive Advancements in Oncology Treatments

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, …

Forbes: Sure, We'll (Eventually) Beat Cancer. But Can We Afford To?

On May 19, Paul Howard highlighted the promise of immunotherapy for the treatment and possible …

Immuno Oncology - A 30-year Overnight Success Story

“It was the Rodney Dangerfield space – couldn’t get no respect” One would never guess …

2013 Novel Drug Approvals

The FDA approved 24 novel drugs last year by our count, in line with average …

Ellmers' Cancer Bill Marks 100 Co-Sponsors

Today, Congresswoman Ellmers announced that 100 bipartisan cosponsors have signed on to support her bill …

Medicare Part B: Barriers to Cancer Treatment

The National Patient Advocate Foundation (PAF) has seen a notable rise in calls for assistance …

Reimbursement Cuts Jeopardize Public Health

Just this month physicians who administer lifesaving therapies in their offices are seeing their reimbursements …

Cancer Stem Cell Therapy: Real Or Just Hype?

Also known as tumor-initiating cells, cancer stem cells (CSC) have unique capability endemic to stem …

Childhood Cancer Groups Join Forces to Train Childhood Cancer Leaders

Cancer remains the leading cause of death by disease for children in the United States …